LynxCare Company Overview
LynxCare is at the forefront of the healthcare data revolution, addressing the challenge of siloed health data in various languages and software systems. The company utilizes AI and NLP to unlock structured and unstructured clinical data, creating federated clinical data warehouses. LynxCare's expertise prepares hospitals for the future within the European Health Data Space, with a team comprising biomedical and data scientists, including over 30% with PhDs from diverse cultural backgrounds. The company offers automated scripts to transform (semi-) structured data to OMOP CDM and is connected with over 20 healthcare information systems, enabling seamless connectivity. Additionally, LynxCare is an EHDEN-certified SME, further highlighting its commitment to advancing healthcare data integration and interoperability
LynxCare Stock Price
The stock price of LynxCare can be calculated by taking the valuation of the company divided by the number of shares outstanding. Because a private company can issue new shares at any time, we do not know the current number of shares outstanding.
Buy LynxCare Stock
If you would like to buy shares in LynxCare, please provide your information in the form at the top of this page and click the button titled “I want to buy this stock.”
One of our investor relations team members will contact you to discuss LynxCare stock availability. Note: inquiries are non-binding and shares may only be purchased by accredited investors that meet all eligibility criteria.
UpMarket has offered many similar companies as Pre-IPO investments, including Airbnb, SpaceX, ByteDance, Plaid, Kraken, Databricks, and others. UpMarket also often has funds available that invest in a portfolio of companies potentially including, LynxCare as well.
LynxCare Management
Name | Position |
---|---|
Georges De Feu | CEO |
Geert Van Gorp | CTO |